Protocol:PRO15070638
Condition or Disease: Von Willebrand disease (vWD)
Study Type: Interventional (Clinical Trial)
Status: Opening Late 2018
Study Title: The VWD Minimize Menorrhagia (VWDMin) Trial
Principal I investigator: Joseph Lasky III, MD
Blog
Hemophilia Patient Receives FDA Approved Gene Therapy Treatment
Cure 4 The Kids Foundation is the First Facility In Nevada To Administer Transformative Therapy
August 19, 2024
